Skip to content
LexBuild

Importer of Controlled Substances; Notice of Application

---
identifier: "/us/fr/E9-28824"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Importer of Controlled Substances; Notice of Application"
title_number: 0
title_name: "Federal Register"
section_number: "E9-28824"
section_name: "Importer of Controlled Substances; Notice of Application"
positive_law: false
currency: "2009-12-02"
last_updated: "2009-12-02"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "E9-28824"
document_type: "notice"
publication_date: "2009-12-02"
agencies:
  - "Justice Department"
  - "Drug Enforcement Administration"
fr_citation: "74 FR 63155"
fr_volume: 74
---

#  Importer of Controlled Substances; Notice of Application

This is notice that on July 1, 2009, Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the basic classes of controlled substances listed in schedule II:

| Drug | Schedule |
| --- | --- |
| Opium, raw (9600) | II |
| Poppy Straw Concentrate (9670) | II |

The company plans to import the basic classes of controlled substances for manufacture of active pharmaceutical ingredients for sale to its customers.

As explained in the Correction to Notice of Application pertaining to Rhodes Technologies, 72 FR 3417 (2007), comments and requests for hearings on applications to import narcotic raw material are not appropriate.

As noted in a previous notice published in the *Federal Register* on September 23, 1975, (40 FR 43745), all applicants for registration to import a basic class of any controlled substances in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.

Dated: November 23, 2009.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.